Professor Malik’s Inaugural Lecture explores the translational journey of emerging phage therapeutics from laboratory discovery to regulated, approved medicines.

Spotlighting cutting-edge research in bioprocess engineering, he will examine how stirred-tank bioreactors and high-throughput scale-down models are used to optimise upstream production yields.

He will also discuss the use of scalable downstream purification strategies to remove impurities, as well as advanced formulation and delivery technologies, including controlled-release micro- and nano- capsules.Finally, he will showcase real-world interdisciplinary applications, demonstrating how bacteriophages can be delivered via nebulisation to treat human respiratory infections and integrated into food production systems.

Join Professor Malik to discover how scalable manufacturing, smart delivery systems and regulatory science are turning biological predators into the standard-of-care medicines of tomorrow.